封面
市场调查报告书
商品编码
1692368

军团菌检测市场 - 全球产业规模、份额、趋势、机会和预测,按类型、最终用途(微生物培养、直接萤光抗体染色、PCR、其他)、按地区和竞争细分,2020-2030 年预测

Legionella Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End Use (Microbial culture, Direct fluorescent antibody stain, PCR, Others), By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球军团菌检测市场价值为 2.8425 亿美元,预计到 2030 年将达到 4.8715 亿美元,预测期内复合年增长率为 9.39%。全球军团菌检测市场是指用于检测和监测军团菌细菌(特别是导致军团病的嗜肺军团菌种)的诊断测试和服务市场。退伍军人症是一种严重的肺炎,可透过吸入受污染的水滴感染,通常来自冷却水塔、热水浴缸和管道系统等来源。据美国疾病管制与预防中心称,2018 年报告了约 10,000 例军团病病例。

市场概况
预测期 2026-2030
2024 年市场规模 2.8425亿美元
2030 年市场规模 4.8715亿美元
2025-2030 年复合年增长率 9.39%
成长最快的领域 聚合酶连锁反应
最大的市场 亚太地区

军团菌在热水环境中旺盛生长,使得依赖储水的产业(如学校、餐厅、医院和大型管线系统)特别容易受到军团菌的污染。因此,这些产业对于军团菌及其相关感染的准确、及时诊断的需求日益增长。 2022年9月,阿根廷圣米格尔德图库曼爆发严重肺炎,造成4人死亡,11人重症。后来,人们将这次疫情与军团菌,特别是嗜肺军团菌连结起来。此外,2022 年 6 月,纽约州总检察长与 Verizon 达成协议,确保该公司采取迅速全面的行动,防止退伍军人病在整个纽约州蔓延。

主要市场驱动因素

测试技术的进步

主要市场挑战

缺乏标准化测试协议

主要市场趋势

快速诊断测试

目录

第 1 章:产品概述

第 2 章:研究方法

第 3 章:执行摘要

第 4 章:顾客之声

第 5 章:全球军团菌检测市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依类型(水质检测、IVD检测)
    • 依最终用途(微生物培养、直接萤光抗体 (DFA) 染色、PCR、其他)
    • 按地区
    • 按公司分类(2024)
  • 产品市场图
    • 按类型
    • 按最终用途
    • 按地区

第 6 章:北美军团菌检测市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 加拿大
    • 墨西哥

第 7 章:欧洲军团菌检测市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 英国
    • 法国
    • 义大利
    • 西班牙

第 8 章:亚太军团菌检测市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 日本
    • 印度
    • 澳洲
    • 韩国

第 9 章:南美洲军团菌检测市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章:中东和非洲军团菌检测市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 近期发展
  • 合併与收购
  • 产品发布

第 13 章:波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章:竞争格局

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • BIOMERIEUX SA
  • Eiken Chemical Co., Ltd
  • Hologic Inc.
  • Pro-Lab PLC
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

第 15 章:策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 20921

Global Legionella Testing Market was valued at USD 284.25 million in 2024 and is expected to reach USD 487.15 million by 2030 with a CAGR of 9.39% during the forecast period. The Global Legionella Testing Market refers to the market for diagnostic tests and services used to detect and monitor Legionella bacteria, particularly the Legionella pneumophila species, responsible for causing Legionnaires' disease. Legionnaires' disease is a severe form of pneumonia that can be contracted through inhalation of contaminated water droplets, typically from sources like cooling towers, hot tubs, and plumbing systems. According to the Centers for Disease Control and Prevention, approximately 10,000 cases of Legionnaires' disease were reported in 2018.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 284.25 Million
Market Size 2030USD 487.15 Million
CAGR 2025-20309.39%
Fastest Growing SegmentPCR
Largest MarketAsia Pacific

Legionella bacteria thrive in hot water conditions, making industries that rely on water storage, such as schools, restaurants, hospitals, and large plumbing systems, particularly susceptible to Legionella contamination. As a result, there is a growing demand across these industries for accurate and timely diagnosis of Legionella and related infections. In September 2022, an outbreak of severe pneumonia in San Miguel de Tucuman, Argentina, resulted in four deaths and 11 cases of severe illness. This outbreak was later linked to Legionella, specifically the bacterium L. pneumophila. Additionally, in June 2022, the New York Attorney General reached an agreement with Verizon to ensure the company takes swift and comprehensive action to prevent the spread of Legionnaires' disease throughout New York State.

Key Market Drivers

Advances in Testing Technologies

The Global Legionella Testing Market is experiencing substantial growth, and one of the key drivers behind this expansion is the continuous advancement of testing technologies. Legionella, a bacterium responsible for Legionnaires' disease, poses a significant public health risk. The need for rapid, sensitive, and accurate testing methods has driven innovation in the field.

Traditional methods of detecting Legionella bacteria, such as culture-based techniques, can be time-consuming and may not always yield accurate results. In contrast, modern molecular techniques, particularly Polymerase Chain Reaction (PCR), have revolutionized Legionella testing. PCR allows for the rapid and precise detection of Legionella DNA in water and environmental samples, significantly reducing the time required for diagnosis. The ability to provide quicker and more accurate results is a key factor driving the demand for Legionella testing services.

The sensitivity of testing methods is crucial when dealing with potentially harmful microorganisms like Legionella. Advances in testing technologies have led to the development of highly sensitive assays. These assays can detect even trace amounts of Legionella bacteria in various samples, including water systems, cooling towers, and air. Enhanced sensitivity ensures that potential sources of contamination are not overlooked, thereby improving the overall safety of water systems.

Automation in testing technologies has not only sped up the testing process but has also minimized the potential for human error. Automated platforms reduce the manual handling of samples, leading to greater consistency and reliability in test results. This feature is especially important in Legionella testing, where accuracy is critical for public health and safety.

Key Market Challenges

Lack of Standardized Testing Protocols

One of the primary challenges in the Legionella testing industry is the absence of standardized testing protocols. Different laboratories and testing facilities may use varying methods and equipment, leading to potential inconsistencies in results. Standardization is crucial to ensure that test results are accurate and can be reliably interpreted.

Key Market Trends

Rapid Diagnostic Tests

Rapid diagnostic tests are set to revolutionize the Legionella Testing Market. These tests offer quicker results, typically within hours, as opposed to the days required by traditional methods. Their speed and accuracy make them invaluable for timely decision-making in Legionella risk management. As demand for fast and reliable testing increases, rapid diagnostic tests will likely gain significant traction.

Key Market Players

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • BIOMERIEUX SA
  • Eiken Chemical Co., Ltd
  • Hologic Inc.
  • Pro-Lab PLC
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Legionella Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Legionella Testing Market, By Type:

  • Water testing
  • IVD testing

Legionella Testing Market, By End Use:

  • Microbial culture
  • Direct fluorescent antibody (DFA) stain
  • PCR
  • Others

Legionella Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Legionella Testing Market.

Available Customizations:

Global Legionella Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Legionella Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Water testing, IVD testing)
    • 5.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Type
    • 5.3.2. By End Use
    • 5.3.3. By Region

6. North America Legionella Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Water testing, IVD testing)
    • 6.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Legionella Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Legionella Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Legionella Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End Use

7. Europe Legionella Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Water testing, IVD testing)
    • 7.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Legionella Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End Use
    • 7.3.2. United Kingdom Legionella Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End Use
    • 7.3.3. France Legionella Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Legionella Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Legionella Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End Use

8. Asia-Pacific Legionella Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Water testing, IVD testing)
    • 8.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Legionella Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End Use
    • 8.3.2. Japan Legionella Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End Use
    • 8.3.3. India Legionella Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End Use
    • 8.3.4. Australia Legionella Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End Use
    • 8.3.5. South Korea Legionella Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End Use

9. South America Legionella Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Water testing, IVD testing)
    • 9.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Legionella Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Legionella Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Legionella Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Legionella Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Water testing, IVD testing)
    • 10.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Legionella Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Legionella Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Legionella Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End Use
    • 10.3.4. Kuwait Legionella Testing Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Abbott Laboratories
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Recent Developments
    • 14.1.5. Financials (As Reported)
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Beckman Coulter, Inc.
  • 14.3. Bio-Rad Laboratories Inc.
  • 14.4. BIOMERIEUX SA
  • 14.5. Eiken Chemical Co., Ltd
  • 14.6. Hologic Inc.
  • 14.7. Pro-Lab PLC
  • 14.8. QIAGEN N.V.
  • 14.9. F. Hoffmann-La Roche Ltd
  • 14.10. Takara Bio Inc.
  • 14.11. Thermo Fisher Scientific Inc.

15. Strategic Recommendations

16. About Us & Disclaimer